ClinicalTrials.gg
CompletedNCT02853838Updated Oct 26, 2016

Chest Physiotherapy in Infants Between 0 and 12 Months Old With Acute Bronchiolitis SRV(+)

An interventional study of Prolonged slow expiration+provoked coughing and Manual chest wall vibration in Bronchiolitis, Viral, sponsored by Universidad del Desarrollo. Completed at 1 site in Chile. Open to participants aged 15 Days to 12 Months. Per ClinicalTrials.gov, last updated 2016-10-26.

Sponsored by Universidad del Desarrollo · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
204
Allocation
Randomized
Ages
15 Days to 12 Months
Sex
All
01

Study summary

The purpose of this research is to determine the effect of prolonged slow expiration techniques, provoked coughing and standard therapy compared to chest wall manual vibration and standard therapy in infants between 0 and 12 months old with confirmed diagnosis of acute bronchiolitis SRV (+). The effect will be measured on respiratory insufficiency and use of supplementary oxygen.

Read the detailed description

Bronchiolitis is the main cause of hospital admission for infants under 1 year old in Chile. Currently, approximately 4800 children are admitted to the hospital during the cold season, affecting the health services' effectiveness. The most frequent causal agent is the Respiratory Syncytial Virus (RSV). To date, there is no specific treatment for this disease and only support measures are recommended.

Chest physiotherapy is a support measure that improves the mucociliary clearance and reduces obstruction of the airways.

A clinical trial on the effect of prolonged slow expiration (PSE), chest wall vibrations, and provoked coughing as treatment for bronchiolitis in infants admitted to the hospital found that the subgroup with RSV required oxygen for 10 hours less than the control group. Gomes and Postiaux (2012) reported a 50% decrease on respiratory distress measured by the Wang score when PSE and suction were compared to traditional chest physiotherapy techniques in patients with bronchiolitis RSV(+).

Currently recommendations in Chile suggest chest physiotherapy for outpatients with bronchiolitis, but the guideline does not refer to the case of inpatients. It is proposed to carry out a randomized controlled trial in infants under one year old. The active group will receive standard therapy, PSE, and provoked coughing, while the control group will receive standard therapy and manual chest wall vibrations. The effectiveness of chest physiotherapy will be measured though a clinical score of respiratory distress, hours using supplementary oxygen, vital signs before and after the intervention in both groups during hospital stay. The main outcome is clinical severity score 48 hours after admission.

02

Conditions studied

  • Bronchiolitis, Viral

Browse trials for

Keywords

  • acute viral bronchiolitis
  • respiratory syncytial virus
  • chest physiotherapy
03

In context

Bronchiolitis, Viral

30 studies on the registry are indexed under Bronchiolitis, Viral; 2 are open to participants now.

This study's enrollment of 204 is above the median of 85 across 25 interventional studies indexed under Bronchiolitis, Viral.

Browse Bronchiolitis, Viral studies →

Lead sponsor

Universidad del Desarrollo is the lead sponsor of 24 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Days to 12 Months
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Clinical diagnosis of bronchiolitis.
  • RSV positive in direct immunofluorescence assay.
  • Wang clinical severity score ≥ 4 points.

Exclusion criteria

Exclusion Criteria:

  • Patients with heart or neurological diseases.
  • Previous episodes of wheezing.
  • Chronic conditions such as bronchopulmonary dysplasia, immunodeficiency, or congenital diseases.
  • Need of mechanical ventilation in Intensive Care Unit
  • criteria for chest physiotherapy (i.e. Pneumothorax, ribs fractures, hemodynamic instability).
  • Patients not receiving supplementary oxygen.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
204 participants (actual)

Study arms

  • Experimental
    Prolonged slow expiration+provoked coughing+ST

    Prolonged slow expiration+provoked coughing+Standard Therapy

    Other: Prolonged slow expiration+provoked coughing · Other: Standard Therapy

  • Active comparator
    Manual chest wall vibration+ST

    Manual chest wall vibration+Standard Therapy

    Other: Manual chest wall vibration · Other: Standard Therapy

Interventions

  • OtherProlonged slow expiration+provoked coughing

    Five cycles of prolonged slow expiration and provoked coughing, which will be repeated five times. During the prolonged slow expiration, the infant will be in supine while the therapist applies pressure at the same time on the rib cage and abdomen during spontaneous expiration. The pressure is applied slowly during two o three respiratory cycles, only during the final phase of expiration.

  • OtherManual chest wall vibration

    Five cycles of manual chest wall vibrations during 20 seconds each, being repeated five times. The manual chest wall vibrations are oscillatory maneuvers applied on the thorax to improve mucociliary clearance of bronchial mucus and ease its removal.

  • OtherStandard Therapy

    Standard therapy (ST): nasopharyngeal suction, oxygen therapy, fluids administration, 0.5% adrenaline nebulization, and chest physiotherapy.

06

What researchers measure

Primary outcomes

  1. Clinical score of respiratory distress

    Wang clinical severity score

    Time frame: 48 hours after baseline measurement

Secondary outcomes

  1. Hours of supplementary oxygen

    Time frame: 48 hours after baseline measurement

  2. Peripheral blood oxygen level

    Oxygen level or saturation is measured with a pulse oximeter

    Time frame: Baseline, 30 min, 60 min, 120 min,12 hours, 24 hours, 36 hours, and 48 hours.

  3. Heart rate

    Time frame: Baseline, 30 min, 60 min, 120 min,12 hours, 24 hours, 36 hours, and 48 hours.

  4. Respiratory rate

    Wang clinical severity score

    Time frame: Baseline, 30 min, 60 min, 120 min,12 hours, 24 hours, 36 hours, and 48 hours.

  5. wheezing

    Wang clinical severity score

    Time frame: Baseline, 30 min, 60 min, 120 min,12 hours, 24 hours, 36 hours, and 48 hours.

  6. Rib cage retractions

    Wang clinical severity score

    Time frame: Baseline, 30 min, 60 min, 120 min,12 hours, 24 hours, 36 hours, and 48 hours.

  7. General clinical condition

    Wang clinical severity score

    Time frame: Baseline, 30 min, 60 min, 120 min,12 hours, 24 hours, 36 hours, and 48 hours.

Other outcomes

  1. Transfer to high complexity unit

    Categorical variable. Record of number of patients requiring treatment at a higher complexity unit (i.e. ICU)

    Time frame: 96 hours

07

Study locations

1 site
  • Hospital Padre Hurtado
    Santiago, Región Metropolitana, Chile
08

References and documents

Individual participant data

Plan to share: Undecided — Data will be made available, If journal where report will be published requires to give access to individual patient data

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 26, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02853838
Lead sponsor
Universidad del Desarrollo
Collaborators
Hospital Padre Hurtado
Responsible party
Patricio Gomolan Gonzalez (Lecturer, Universidad del Desarrollo) — Principal investigator
First posted
Aug 3, 2016
Start date
Mar 2015
Primary completion
Sep 2016
Completion
Oct 2016
Last update
Oct 26, 2016

Study contacts

Patricio Gomolán
principal investigator · Universidad del Desarrollo

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion